Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide analogues as novel treatments for Alzheimer's and Parkinson's disease

Hölscher, Christian (2016) Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide analogues as novel treatments for Alzheimer's and Parkinson's disease. Cardiovascular Endocrinology, 5 (3). pp. 93-98. ISSN 2162-688X

[img]
Preview
PDF (Review_Cardiovasc_Endocrin_2016)
Review_Cardiovasc_Endocrin_2016.pdf - Accepted Version
Available under License Creative Commons Attribution-NonCommercial.

Download (547kB)

Abstract

Type 2 diabetes is a risk factor for developing chronic neurodegenerative disorders such as Alzheimer's disease (AD) or Parkinson's disease (PD). The underlying mechanism appears to be insulin desensitization in the brain. A range of glucagon-like peptide 1 (GLP-1) mimetics and glucose-dependent insulinotropic polypeptide (GIP) analogues initially designed to treat diabetes protected transgenic animals that model AD and toxin-based animal models of PD. Novel dual GLP-1/GIP analogues also show good neuroprotective effects. On the basis of these findings, first clinical trials have been conducted. In a pilot study on patients with AD, the GLP-1 analogue liraglutide showed good protective effects in 18 F-fluorodeoxyglucose (18 F-FDG)-PET brain imaging. It was found that the disease-related decay of brain activity had been completely stopped by the drug. In a pilot study in patients with PD, the GLP-1 mimetic exendin-4 showed good protection from motor and cognitive impairments. These results demonstrate the potential of developing disease-modifying treatments for AD and PD.

Item Type:
Journal Article
Journal or Publication Title:
Cardiovascular Endocrinology
Additional Information:
Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.
Uncontrolled Keywords:
/dk/atira/pure/subjectarea/asjc/2700/2724
Subjects:
ID Code:
83718
Deposited By:
Deposited On:
22 Dec 2016 11:02
Refereed?:
Yes
Published?:
Published
Last Modified:
29 Sep 2020 03:20